Spyre Therapeutics (SYRE) Shares Outstanding (Entity) (2015 - 2026)
Powered by 
Analysis
Spyre Therapeutics (SYRE) Shares Outstanding (Entity) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Spyre Therapeutics | 7.35 Bn | 7.35 Bn | - | 88.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.06 Mn |
| Mar 31, 2026 | 78.84 Mn |
| Dec 31, 2025 | 64.42 Mn |
| Sep 30, 2025 | 60.47 Mn |
| Jun 30, 2025 | 60.37 Mn |
| Mar 31, 2025 | 60.28 Mn |
| Dec 31, 2024 | 47.49 Mn |
| Sep 30, 2024 | 51.40 Mn |
| Jun 30, 2024 | 50.78 Mn |
| Mar 31, 2024 | 36.63 Mn |
| Dec 31, 2023 | 7.34 Mn |
| Sep 30, 2023 | 4.05 Mn |
| Jun 30, 2023 | 3.24 Mn |
| Mar 31, 2023 | 3.77 Mn |
| Dec 31, 2022 | 3.37 Mn |
| Sep 30, 2022 | 3.77 Mn |
| Jun 30, 2022 | 3.29 Mn |
| Mar 31, 2022 | 2.64 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Sep 30, 2021 | 2.63 Mn |